Anti-LGALS3 (Oloctinebart biosimilar) mAb (HDBS0647)
- SKU:
- HDBS0647
- Antibody Type:
- Biosimilar Reference Antibody
- Applications:
- IHC
- FC
- Drug Development
- Pharmacokinetics
- Disease Area:
- Cancer
- Size:
- 100 μg
- Target:
- LGALS3
- Isotype:
- IgG4
- Host Species:
- Whole mAb
- Reactivity:
- Human
Description
| Product Name: | Anti-LGALS3 (Oloctinebart biosimilar) mAb |
| SKU: | HDBS0647 |
| Size: | 100 μg |
| Target: | LGALS3 |
| Common Name: | TBC |
| Isotype: | IgG4 |
| Host Species: | Whole mAb |
| Reactivity: | Human |
| Synonyms: | L31;GAL3;MAC2;CBP35;GALBP;GALIG;LGALS2 |
| Conjugate: | Unconjugated |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
| Uniprot: | P17931 |
| Formulation & Reconstitution: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| Usage: | Research use only |
| Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Related Products
Biotinylated Anti-LGALS3 (Oloctinebart biosimilar) mAb (HDBS1016)
€429
Anti-CD93 (Biosimilar) mAb (HDBS0158)
€429
Anti-EPCAM (Oportuzumab biosimilar) mAb (HDBS0165)
€429
Anti-ANGPTL3 (Evinacumab biosimilar) mAb (HDBS0193)
€429
Anti-TNFa (Certolizumab biosimilar) mAb (HDBS0164)
€429